Toronto, Ontario--(Newsfile Corp. - February 6, 2019) - Leviathan Cannabis Group Inc. (CSE: EPIC) (the "Company" or "Leviathan")
reports that the Letter of Intent to acquire all issued and outstanding shares of MariGrow Inc., which was announced on January 17,
2019, has been terminated.
Leviathan continues to explore growth opportunities designed to create strong shareholder value. The Company is actively
reviewing a number of additional production assets as well as other cannabis ecosystem opportunities in Canada, the U.S. and
Europe.
About Leviathan Cannabis
Leviathan plans on executing a series of strategic acquisitions that extend across all vertical markets in Canada and
internationally, to support the Company's proprietary brand strategy. This global reach positions the Company to become a leading
multi-jurisdictional medical and recreational cannabis enterprise - one that brings together the best cannabis products, brands and
expertise from Canada and around the world. The Leviathan portfolio currently comprises Jekyll+Hyde Brand Builders Inc., a
marketing services agency specializing in the cannabis sector, and Woodstock Biomed Inc., a late-stage applicant under the ACMPR,
which is planning to retrofit a substantial greenhouse production facility in Pelham, Ontario, subject to obtaining an exemption
from interim control by-law imposed by the Town of Pelham.
www.LeviathanCannabis.com
For more information, contact Martin J. Doane, CEO, Leviathan Cannabis Group Inc. at 416.903.6691 or Jayne Beckwith, Chief
Communications Officer, Leviathan Cannabis Group Inc. at 416.806.0591.
# # #
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS:
Certain information in this press release constitutes forward-looking statements under applicable securities laws. Any
statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking
statements. Forward-looking statements are often identified by terms such as "may", "should", "anticipate", "expect", "potential",
"believe", "intend" or negatives of these terms and similar expressions.
Forward-looking statements are based on certain assumptions, including successful application to be a licensed cannabis producer
and seller, expected growth, results from operations, performance, industry trends and growth opportunities. While Leviathan
considers these assumptions to be reasonable, based on information currently available, they are inherently subject to significant
business, economic and competitive uncertainties and contingencies and they may prove to be incorrect. Readers are cautioned not to
place undue reliance on forward-looking statements.
Forward-looking statements also necessarily involve known and unknown risks, including without limitation, risks associated with
general economic conditions, adverse industry events, marketing costs, loss of markets, future legislative and regulatory
developments, the inability to access sufficient capital on favourable terms, the medical and recreational cannabis industry in
Canada in general, income tax and regulatory matters, the ability of Leviathan to execute its business strategies, competition,
crop failure, currency and interest rate fluctuations and other risks.
Readers are cautioned that the foregoing is not exhaustive. Readers are further cautioned not to place undue reliance on
forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will
occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and
actual results may differ from those anticipated. Forward-looking statements are not guarantees of future performance. Except as
required by law, Leviathan disclaims any obligation to update or revise any forward-looking statements, whether as a result of new
information, events or otherwise. Forward- looking statements contained in this news release are expressly qualified by this
cautionary statement.
Source: Leviathan Cannabis Group Inc.
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the
Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/42693
